Complex coronary artery disease: would outcomes from the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) trial have differed with newer-generation drug-eluting stents?
作者信息
Farooq Vasim, Serruys Patrick W
机构信息
Department of Interventional Cardiology, Erasmus University Medical Centre, Thoraxcenter, Rotterdam, the Netherlands.
出版信息
JACC Cardiovasc Interv. 2013 Oct;6(10):1023-5. doi: 10.1016/j.jcin.2013.07.004.
PMID:24156963
Abstract
摘要
相似文献
1
Complex coronary artery disease: would outcomes from the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) trial have differed with newer-generation drug-eluting stents?
JACC Cardiovasc Interv. 2013 Oct;6(10):1023-5. doi: 10.1016/j.jcin.2013.07.004.
2
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).XIENCE V 依维莫司洗脱冠状动脉支架系统治疗多支冠状动脉疾病患者的临床和血管造影研究：EXECUTIVE 试验（EXecutive RCT：评估 XIENCE V 在多支血管疾病中的应用）。
JACC Cardiovasc Interv. 2013 Oct;6(10):1012-22. doi: 10.1016/j.jcin.2013.05.016. Epub 2013 Sep 18.
3
Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity.无保护左主干病变和高解剖学冠脉复杂性患者应用依维莫司洗脱支架后的造影和临床结局。
JACC Cardiovasc Interv. 2016 May 23;9(10):1001-7. doi: 10.1016/j.jcin.2016.02.016.
4
The synergy between percutaneous therapies and noninvasive diagnostic imaging.经皮治疗与非侵入性诊断成像之间的协同作用。
JACC Cardiovasc Interv. 2013 Oct;6(10):1010-1. doi: 10.1016/j.jcin.2013.09.003.
5
Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.新-代与早期药物洗脱支架治疗无保护左主干冠状动脉疾病的 3 年疗效和安全性：来自 ISAR-LEFT MAIN 和 ISAR-LEFT MAIN 2 试验的结果。
Clin Res Cardiol. 2016 Jul;105(7):575-84. doi: 10.1007/s00392-015-0953-x. Epub 2015 Dec 22.
6
Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.药物洗脱支架置入治疗无保护左主干冠状动脉疾病后，冠状动脉解剖结构和支架技术对长期预后的影响。
JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11.
7
Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).三维分叉角度对左主干冠状动脉疾病经皮冠状动脉介入治疗后 5 年预后的影响：SYNTAX 试验（紫杉醇药物洗脱支架与心脏搭桥术的联合治疗）的一项亚组研究。
JACC Cardiovasc Interv. 2013 Dec;6(12):1250-60. doi: 10.1016/j.jcin.2013.08.009.
8
Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.经全吸收聚合物雷帕霉素洗脱支架冠状动脉植入治疗初发冠状动脉疾病患者的 5 年临床和功能多层螺旋 CT 血管造影结果：ABSORB 队列 A 试验。
JACC Cardiovasc Interv. 2013 Oct;6(10):999-1009. doi: 10.1016/j.jcin.2013.05.017.
9
Is "the bigger the better" still valid for drug-eluting stents?
Catheter Cardiovasc Interv. 2014 May 1;83(6):879-80. doi: 10.1002/ccd.25478.
10
Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.糖尿病患者接受依维莫司洗脱支架和西罗莫司洗脱支架植入后的内膜增生与血管重塑：随机糖尿病与药物洗脱支架（DiabeDES）IV血管内超声试验
Catheter Cardiovasc Interv. 2014 May 1;83(6):864-72. doi: 10.1002/ccd.25180. Epub 2013 Sep 30.
Zotero 插件